QR Health Solutions Ukraine, Лісозахисний провулок, 5, Kyiv (2025)

03/07/2023

July - the month of umbilical cord blood awareness. 🩸
⠀
🧬 The entire month of July and November 15th each year is dedicated to the advancements and prospects of umbilical cord blood use, as well as the significant contribution of cord blood banks in the study of stem cells and cellular medicine, the development and implementation of new treatment and recovery methods in practical medicine.
⠀
🏥💉 The first evidence of umbilical cord blood's ability to replace bone marrow emerged in the late 1970s. In 1988, the first umbilical cord blood transplant was performed to save an older brother with the cord blood of his younger sister.
⠀
Since then, other types of stem cells and alternative sources for their retrieval have been discovered. However, umbilical cord blood has firmly established itself in cellular therapy as the most affordable source of safe and effective stem cells.
⠀
Currently, umbilical cord blood stem cells are employed in the standard treatment of over 80 serious diseases, including oncology and hematology, severe metabolic and immune disorders, and solid tumors.
⠀
Umbilical cord blood is used in thousands of clinical trials and experimental treatments.
⠀
🔸In July, we are offering a 20% discount on consultations and services at QR Health Solutions Advanced Cell Technology Center in Kyiv for those in need of treatment.
⠀
More about treatments https://qr-clinic.com/en/conditions/

06/09/2022

On February 15, Marshall Glesby, chief of infectious diseases at Weill Cornell Medicine and New York-Presbyterian, made a stunning statement.
⠀
The fourth patient who completely recovered from HIV and stopped taking antiretroviral therapy was a woman from New York.
She had to undergo a hematopoietic stem cell transplant, as the first three patients, known as the Berlin, London and Düsseldorf patients
⠀
As a result of HIV infection, the woman progressed acute myeloid leukemia. Hope for recovery was a transplant of donor stem cells. 🩸Umbilical cord blood was chosen. First of all because the woman belongs to a mixed race, so it was difficult to find an identical bone marrow donor. In addition, the donor cells had to carry a rare HIV-resistant CCR5 mutation, which creates an immune system unfavorable to HIV infection. 🧾It was possible to select the necessary sample of umbilical cord blood thanks to the national registry. The woman also received a small part of bone marrow stem cells from a partially compatible relative. These cells could not take root, but functioned for the first weeks, supporting the umbilical cord blood that formed the new immune system. 💪
⠀
After transplant of stem cells from umbilical cord blood, the woman managed to avoid their rejection (painful graft-versus-host reaction), as opposed to Berlin and London patients who received a transplant of HIV-resistant stem cells from the bone marrow. The woman has been in stable remission from cancer for more than 4.5 years and has stopped taking anti-HIV drugs for more than a year.
⠀
In the world, approximately 38 million people are living with HIV, most of whom are forced to take antiretroviral therapy every day. It would seem that a solution has been found, and possible to cure all patients with umbilical cord blood stem cell transplantation.
But although the results of cell therapy are encouraging, there are several problems with the use of stem cell transplantation as a cure for HIV.
⠀
🔺First, the search for a suitable cord blood sample containing the HIV-resistant CCR5 mutation for each patient.
⠀
🔺The second and more important problem is the stem cell transplantation procedure itself. The chemotherapy required for treatment is extremely dangerous and can cause many serious complications and even death. Given the improved efficacy of antiretroviral therapy in the treatment of HIV infection, intensive chemotherapy that destroys one's own immune system is not justified when trying to cure patients of HIV infection alone.
⠀
But for HIV patients who have faced the need for stem cell transplantation, such therapy is very promising, for example, in the treatment of leukemia

21/02/2022

Autism and Autism Spectrum Disorders are the group of neuropsychiatric disorders that manifest in dysfunction of speech, socialization, motor, and behavioral stereotypes.

Treatment of children with autism with umbilical cord blood and umbilical cord stem cells is considered safe and effective. Stem cells regulate immunity, repair damaged areas of the brain and eliminate inflammation.

After therapy there are such effects: improving the ability to learn, disappearing of aggression and motor disorders, children begin to respond to the name. During the year after the infusion, more than 70% of children show significant progress in socialization and behavior.

The stem cell treatment plan and route of administration are selected individually and depend on the child's age, symptoms, and concomitant diagnoses.

Stem cells cause the child natural processes necessary for recovery:
- synthesis of anti-inflammatory cytokines and growth factors that regulate the immune, endocrine, and nervous systems,
- restoration of damaged areas of the brain and improving the conduction of nerve impulses,
- improving the overall regulation of body systems,
- stimulating the production of own stem cells and self-healing.

17/02/2022

Osteoarthritis (OA) is a chronic disease of the joints, which mainly affects the cartilage and make subsequent changes in bones, ligaments, and the space around the joint tissues. It usually leads to the deformation of the joints in the latest stage of the disease.

Hands, neck and supporting joints (knee, hip, and foot joints) suffer from osteoarthritis most of all. The OA treatment alleviates the patient's condition but doesn’t bring to the total recovery.

Transplantation of Mesenchymal Stem Cells (MSCs) as a treatment of osteoarthritis has become a promising therapy that has huge regenerative, trophic, and immunomodulatory effects.
MSCs can transform into cartilage cells (chondrocytes) and improve cartilage trophism, especially when it is administered intra-articularly.

Clinical research has proven that MSCs therapy:
- reduce pain and inflammation,
- eliminate cartilage defects and restore its normal structure,
- restore natural metabolism in cartilage.

07/02/2022

Acute respiratory distress syndrome (ARDS) is a symptom complex of acute pulmonary insufficiency which is characterized by diffuse infiltration of lung tissue, pulmonary edema, and severe hypoxemia (decreased level of oxygen in the blood).
ARDS can develop at any age. It is accompanied by high mortality, has severe complications, and leaves a poorer quality of life. There is no effective pharmacotherapy, which has been proven by the COVID-19 pandemic and high rate of mortality. The most dangerous is the hyperactive response of the immune system to the SARS-CoV-2 virus which leads to the so-called "cytokine storm". It causes the progression of ARDS very quickly.

Patients who have passed the ARDS continue to suffer from muscle weakness and neuropsychiatric problems. Also, their cardiovascular system has been impaired for a long time.

The invention of drugs for ARDS is complicated because it is not a disease but a syndrome that is characterized by acute respiratory failure which develops de novo (again, from the beginning) at the large list of health conditions.

According to the clinical treatments, Mesenchymal stem cells (MSCs) have shown high efficacy in the treatment of ARDS, including conditions caused by COVID-19.

Treatment of ARDS with MSCs has the following therapeutic effects:
- anti-inflammatory
- immunomodulatory
- anti fibrosis
- proangiogenic
- antioxidant
- antimicrobial

All these effects lead to significant structural and functional recovery of the lungs.

Clinical research has proven that MSC therapy is a successful and promising treatment for acute respiratory distress syndrome, including patients with bilateral pneumonia caused by COVID-19 and leads to effective recovery.

Free consultation:
+38 067 277 24 33 (WhatsApp)
+38 067 223 35 45
qr-clinic.com

Our goal is to provide every patient with the qualitative personalized treatment and give new quality of their life!

19/01/2022

Cell therapy refers to regenerative medicine which is aimed to treat and restore the functions of damaged tissues and organs.

As well as human body regenerative medicine uses stem cells to repair damaged tissues, to rehabilitate and fight severe and chronic diseases. Stem cells are considered one of the most powerful tools in the treatment of complex diseases.

WHAT ARE MESENCHYMAL STEM CELLS (MSCS)?

MSCs are non-hematopoietic multipotent stromal cells that originate from different types of tissues, including bone marrow, adipose tissue, tooth pulp, placenta and umbilical cord.

They can transform into cells of any type - bone, connective, cartilage, brain, heart cells, nerve, liver cells and more. However, not all types of stem cells have such ability.
It has been found that only mesenchymal stromal cells (MSCs) are able to transform into most cell types and are being successfully and safely used in medicine in diseases’ treatments.

QR Health Solutions uses several types of stem cells: mesenchymal stem cells of the umbilical cord, placenta, adipose tissue, nerve crest and hematopoietic stem cells of umbilical cord blood.

THERAPEUTIC PROPERTIES OF MSC:
• High proliferative potential - the ability to transform into other cells of the body
• No risk of infection with viruses
• Do not cause immune rejection or tumors
• Suitable for autologous and allogeneic use
• Induce angiogenesis
• Promote neurogenesis, have neuroprotection
• Reduce inflammation
• Suppress apoptosis - "programmed cell death"
• Activate own stem cells

QR Health Solutions conducts stem cell therapy in the following areas:
• Neurology
• Cardiology
• Orthopedics
• Endocrinology
• Immunotherapy
• “Longevity +” program

Stem tissue therapy is a new possibility of modern medicine!
We offer an individual treatment plan that will work the best for the patient's condition!

Free consultation:
+38 067 277 2433 - WhatsApp
+38 067 223 3545
qr-clinic.com

Our goal is to provide every patient with the qualitative personalized treatment and give new quality of their life!

17/01/2022

QR Health Solutions is a modern Center of excellence for advanced stem cell therapy and regenerative medicine.
The history of the Center began in 2005 with the family umbilical cord blood bank "HEMAFUND". For the first time our clients got their stem cell treatments in 2009 at specialized medical institutions in partnership with leading international medical institutions and research centers.

Since then, more than 200 families have received therapy using preserved cells from postnatal material, from their own adipose tissue or mesenchymal stromal cells received from the donor umbilical cord.

The gained experience allowed us to get support and conduct mutual science research with the leading International and Ukrainian research scientific centers in the field of stem cell therapy.

The practice has proven that stem cells are valuable biological material that has become a scientific breakthrough in the treatment of incurable and chronic diseases.

QR Health Solutions offers individualized treatment plans with techniques based on the highest standards of safety and quality for patients.

We have involved the best specialists with successful experience in the field of cell therapy in the following areas:
• Neurology
• Cardiology
• Orthopedics
• Endocrinology
• Immunotherapy
• Comprehensive program Longevity +

QR Health Solutions Center is part of the HEMAFUND Group of companies.
It combines extensive opportunities and includes:
- Cryobank for stem cell storage
- Clinical and diagnostic laboratories for material testing, stem cell processing and cultivation laboratories
- Department of clinical research
- Clinic for stem cell therapy - QR Health Solutions

Call and get a free consultation:
+38 067 277 24 33 - WhatsApp
+38 067 223 35 45
qr-clinic.com

Our goal is to provide every patient with the qualitative personalized treatment and give new quality of their life!

14/11/2020

📆Сьогодні відзначають Всесвітній день боротьби з цукровим діабетом. В цей день будуть часто лунати невтішні цифри і сумні прогнози.

❤️Ми ж скажемо про надію, адже цукровий діабет не вирок! Цю надію нам дає невпинний розвиток світової медицини та поява новітніх методів терапії захворювань, які ми звикли називати невиліковними.

Бажаємо Вам здорового, якісного та приємного життя, життя з надією!🙏

З питаннями до наших спеціалістів з клітинної терапії при цукровому діабеті 2 типу Ви можете звернутись за телефоном: +38 (067) 223-35-45

30/10/2020

🦠 Слово «Ковід» стало повсякденним для усього світу за цей рік. Пандемія ще триває, але вчені та медики вже говорять про інший бік цієї недуги, а саме про подолання її наслідків. З’явилися такі поняття, як «синдром пост-Covid» та «тривалий Covid».

Тривалі респіраторні захворювання або так званий гострий респіраторний дистрес синдром (ГРДС) уражають легеневу тканину та спричиняють неприємні наслідки, які знижують якість життя та здатність повністю відновитися.

😷 Свій стан пацієнти часто описують як часту задишку, навіть при незначних фізичних навантаженнях, втомлюваність, неможливість вдихнути “на повні груди“. Зниження ефективної дихальної функції легень приводить до гіпоксії тканин і органів, що порушує роботу всіх систем організму, в першу чергу серцево-судинної та нервової.

🔬Застосування мезенхімальних стовбурових клітин для подолання наслідків коронавірусної хвороби проводять в усіх прогресивних країнах світу. На сьогодні вже опубліковано 118 наукових праць (https://pubmed.ncbi.nlm.nih.gov/?term=msc+covid). Відновлення після тяжкого перебігу захворювань легень та гострого респіраторного дистрес-синдрому за допомогою клітинної терапії можливе в Україні.

🏥Медичний центр ГЕМАФОНД разом з Центр Передових Клітинних технологій QR Health Solutions отримали патент на СПОСІБ ЛІКУВАННЯ ГОСТРОГО РЕСПІРАТОРНОГО ДИСТРЕС-СИНДРОМУ ЛЕГЕНЬ ІНФЕКЦІЙНОГО ТА НЕІНФЕКЦІЙНОГО ГЕНЕЗУ за допомогою мезенхімальних стовбурових клітин.

При лікуванні наслідків ГРДС, терапія з використанням МСК має:

✅ імуномодулюючий ефект (сприяє нормалізації роботи імунної системи);
✅ стимулює відновлення пошкоджених тканин (покращує живлення легеневої тканини за рахунок секреції низки трофічних факторів);
✅ зменшує фіброз легеневої тканини, збільшує життєву ємність легень;
✅ дозволяє уникнути активізації хронічних хвороб на фоні перенесеного ГРДС;
✅ відновлює після інтенсивного лікування препаратами або ШВЛ.

За більш детальною інформацією звертайтеся за телефоном: ☎️ +38 (067) 223-35-45.

Деталі на сайті: https://qr-clinic.com/conditions/naslidky-hostroi-lehenevoi-nedostatnosti/

#клітиннатерапія #стовбуровіклітини #ковід19 #пневмонія

QR Health Solutions Ukraine

03/07/2023

06/09/2022

21/02/2022

17/02/2022

07/02/2022

19/01/2022

17/01/2022

14/11/2020

30/10/2020

Address

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share

Category